The World Health Organization (THAT) Has Announced the DELIVERY OF LEPROSY MEDICINES to Nigeria After A Year-Long Hold-Up,Reuters News Agency Reported
Un Special Rapportur Beaanda-Galarza Cited Testing Issues and Systemic Vulnerabilities as Reasons for theDelay The Drugs desires Reportedly Arrive in Nigeria on Sunday.
Nigeria’s Ongoing Leprosy Crisis
Nigeria, Africa’s Most Populous Nation, Records Over 1,000Leprosy Cases Annually The Disease, Caused by Mycobacterium Leprae, Affects the Skin, Peripheral Nerves andEyes It is treatable with Multi-Drug Therapy (MDT), however without therapy clients Suffer from injuring sores, loss of sight and paralysis.
” Before Last Year, My Wound’s Were Healing, But Now They Are Worse,”Awwal Musa Told Reuters Musa’s fingers are Clawed and Legs Discharge Pus Due to the Lack of Medicine.
Delayed Drug Requests
Leprosy is Present in 12 Countries Worldwide, with Nigeria, Brazil, India, and Indonesia Among the Most Impacted, Reporting Between 10,000 to Annually.
The Swiss Pharmaceutical Company Novartis Manufactures andDonates Leprosy Drugs To The Who A Spin-Off Company Produces The Medication in Indian Facilities Before Singing IT for Additional Testing in Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC).
India-Based Laboratory Quontrol, Told Reuters That The Drugs Were Submitted For Testing in Nigeria in November and Approved in December 2024. Nigeria’s Leprosy Control Did not Comment on Why The Drugs Remained Delayed Afer Approval.
Each Country Must Request Doses of Leprosy Drugs, which Are Administration Over aYear According to Health Sources in Nigeria, The Country was Late in Submitting Its Request, Contributing to Delay and Subsquent Shortage.
Edited by: Sean Sinico, Wesley Dockery
